Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CRAI | FLNC |
|---|---|---|
| Price | $174.94 | $7.67 |
| Change today | ▲ 2.05% | ▼ 4.48% |
| Market cap | $1.10B | $1.10B |
| Return, 3 months | +12.2% | -54.2% |
| Return, year to date | -11.9% | -61.2% |
| Return, 1 year | -2.7% | -48.7% |
| P/E (TTM) | 23.3 | -12.8 |
| P/B | 6.0 | 2.9 |
| P/E percentile vs own 5y | 64th | 76th |
| Dividend yield | 1.26% | – |
| Revenue growth (YoY, latest qtr) | +12.8% | +7.9% |
| Net profit growth (YoY) | +11.4% | -742.2% |
| Gross margin | 29.0% | 9.3% |
| Operating margin | 10.0% | -4.2% |
| Net margin | 6.2% | -3.1% |
| Return on equity | 26.0% | -20.7% |
| Analyst target vs. price | +40.0% | +57.2% |
| Analyst buy share | 50% | 24% |
| RSI (14) | 60 | 36 |
| 30-day volatility | 29.9% | 74.2% |
| Max drawdown, 1 year | -38.1% | -77.4% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
